Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Exosome-based layered double hydroxide nanohybrids from adipose-derived stem cells enhance dermal wound healing.

Shavandi M., Shafiei SS., Salimi M.

Animal Study on Chronic Wound, published in Sci Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Rep (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41486200
PMCID
PMC12873175
DOI
10.1038/s41598-025-34937-w

Abstract (original English)

Exosomes are rapidly emerging as a novel field in wound healing. Wound healing is a complex phenomenon characterized by a series of dynamic physiological functions. Despite the promising benefits of using exosomes for wound healing, many challenges remain to be addressed. Advances in nanotechnology and regenerative medicine have led to the development of hybrid systems that combine the advantageous properties of exosomes and nanoparticles, significantly enhancing wound healing outcomes. In this study, exosomes were isolated from human Adipose-Derived Stem Cells (ADSCs). Layered double hydroxide (LDH) was synthesized, and LDH/Exosome (LDH/Exo) nanohybrids were prepared. Following the successful characterization of exosomes, the LDH/Exo nanohybrid was assessed using field emission scanning electron microscopy (FE-SEM), Fourier-transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), and energy-dispersive X-ray spectroscopy (EDX). Our results showed that the LDH enabled the sustained release of the exosomes, especially during the early stage. Cell viability and scratch assay analyses were performed to evaluate the potential of LDH/Exo nanohybrid systems in wound healing. Also, a dose-dependent reduction in bacterial growth indicated the antimicrobial activity. The results demonstrated that the chemical structures and morphology of exosomes remained intact. Additional

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Wound HealingHumansHydroxidesExosomesStem CellsAdipose TissueCell SurvivalMiceNanoparticlesAnimals

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research